Literature DB >> 32045491

Water for preventing urinary stones.

Yige Bao1, Xiang Tu2, Qiang Wei1.   

Abstract

BACKGROUND: Urinary stone disease is a common condition characterised by increasing prevalence and high rates of recurrence. Observational studies have reported that increased water intake played a role in the prevention of urinary stone formation but with limited strength of evidence.
OBJECTIVES: To compare the effects of increased water intake with standard water intake for the prevention of urinary stone formation in participants with or without a history of urinary stones. SEARCH
METHODS: We performed a systematic search of PubMed (MEDLINE), EMBASE (Ovid) and the Cochrane Library to 15 October 2019. We handsearched review articles, clinical trial registries, and reference lists of retrieved articles. We did not apply any restrictions to publication language or publication status. SELECTION CRITERIA: We included randomised controlled trials (RCTs) and quasi-RCTs looking at the benefits and harms of increased water intake versus standard water intake for the prevention of urinary stone formation in participants with or without a history of urinary stones. DATA COLLECTION AND ANALYSIS: We used standard methodological procedures expected by Cochrane. Two review authors independently extracted data and assessed the risk of bias of included studies. We pooled dichotomous outcomes (e.g. incidence/recurrence rate of urinary stones; adverse events) using risk ratios (RRs) with 95% confidence intervals (CIs). We calculated hazard ratio (HRs) and corresponding 95% CIs to assess the intervention effect for time-to-event outcomes. We assessed the certainty of the evidence by using the GRADE criteria. MAIN
RESULTS: Our search identified no RCTs investigating the role of increased water intake for the prevention of urinary stone formation in participants with no history of urinary stones (primary prevention). We found one RCT assessing the effects of increased water intake versus standard water intake for the prevention of urinary stone formation in people with a history of urinary stones (secondary prevention). This trial randomised 220 participants (110 participants in the intervention group with increased water intake and 110 in the control group with standard water intake). Increased water intake was defined as achieving a urine volume of at least 2.0 L per day by drinking water. Based on this study, increased water intake may decrease stone recurrences (RR 0.45, 95% CI 0.24 to 0.84; 199 participants; low-certainty evidence); this corresponds to 149 fewer (43 fewer to 205 fewer) stone recurrences per 1000 participants with 270 stone recurrence per 1000 participants over five years in the control group. Increased water intake may also prolong the time to urinary stone recurrence compared to standard water intake (HR 0.40, 95% CI 0.20 to 0.79; 199 participants; low-certainty evidence); based on a stone recurrence rate of 270 per 1000 participants over five years, this corresponds to 152 fewer (209 fewer to 50 fewer) recurrences per 1000 participants. For both outcomes we downgraded the certainty of evidence for study limitations and imprecision. We found no evidence for the outcome of adverse events AUTHORS'
CONCLUSIONS: We found no RCT evidence on the role of increased water intake for primary prevention of urinary stones. For secondary prevention, increased water intake achieving a urine volume of at least 2.0 L/day may reduce urinary stone recurrence and prolong time to recurrence for people with a history of urinary stone disease. However, our confidence in these findings is limited. We did not find evidence for adverse events.
Copyright © 2020 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32045491      PMCID: PMC7012319          DOI: 10.1002/14651858.CD004292.pub4

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  56 in total

1.  Dietary and pharmacologic management to prevent recurrent nephrolithiasis in adults: a clinical practice guideline from the American College of Physicians.

Authors:  Amir Qaseem; Paul Dallas; Mary Ann Forciea; Melissa Starkey; Thomas D Denberg
Journal:  Ann Intern Med       Date:  2014-11-04       Impact factor: 25.391

2.  Quantifying heterogeneity in a meta-analysis.

Authors:  Julian P T Higgins; Simon G Thompson
Journal:  Stat Med       Date:  2002-06-15       Impact factor: 2.373

3.  Prevention of recurrent nephrolithiasis in adults.

Authors:  Amir Qaseem; Howard A Fink; Thomas D Denberg
Journal:  Ann Intern Med       Date:  2015-04-07       Impact factor: 25.391

4.  [Urolithiasis prevalence and risk factors in Yucatan, Mexico].

Authors:  Martha Medina-Escobedo; Mussaret Zaidi; Elizabeth Real-de León; Sergio Orozco-Rivadeneyra
Journal:  Salud Publica Mex       Date:  2002 Nov-Dec

5.  The stone clinic effect in patients with idiopathic calcium urolithiasis.

Authors:  D H Hosking; S B Erickson; C J Van den Berg; D M Wilson; L H Smith
Journal:  J Urol       Date:  1983-12       Impact factor: 7.450

Review 6.  Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline.

Authors:  Howard A Fink; Timothy J Wilt; Keith E Eidman; Pranav S Garimella; Roderick MacDonald; Indulis R Rutks; Michelle Brasure; Robert L Kane; Jeannine Ouellette; Manoj Monga
Journal:  Ann Intern Med       Date:  2013-04-02       Impact factor: 25.391

Review 7.  Treatment effect, adherence, and safety of high fluid intake for the prevention of incident and recurrent kidney stones: a systematic review and meta-analysis.

Authors:  Wisit Cheungpasitporn; Sandro Rossetti; Keith Friend; Stephen B Erickson; John C Lieske
Journal:  J Nephrol       Date:  2015-05-29       Impact factor: 3.902

8.  Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up.

Authors:  Eric N Taylor; Meir J Stampfer; Gary C Curhan
Journal:  J Am Soc Nephrol       Date:  2004-12       Impact factor: 10.121

9.  The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration.

Authors:  Alessandro Liberati; Douglas G Altman; Jennifer Tetzlaff; Cynthia Mulrow; Peter C Gøtzsche; John P A Ioannidis; Mike Clarke; P J Devereaux; Jos Kleijnen; David Moher
Journal:  BMJ       Date:  2009-07-21

Review 10.  Pharmacological interventions for preventing complications in idiopathic hypercalciuria.

Authors:  Joaquin Escribano; Albert Balaguer; Filomena Pagone; Albert Feliu; Marta Roqué I Figuls
Journal:  Cochrane Database Syst Rev       Date:  2009-01-21
View more
  5 in total

1.  Effect of rapid rehabilitation nursing on improvement of quality of life after super-miniPCNL and risk analysis for postoperative complications.

Authors:  Lei Yang; Qianhong Liu; Qun Chi; Jingjing Li
Journal:  Am J Transl Res       Date:  2022-07-15       Impact factor: 3.940

2.  Ample dietary fat reduced the risk of primary vesical calculi by inducing macrophages to engulf budding crystals in mice.

Authors:  Huiling Chen; Kaiqiang Hu; Yaru Liang; Yuqi Gao; Chenye Zeng; Kang Xu; Xiaojin Shi; Liyuan Li; Yuemiao Yin; Yi Qiao; Ying Qiu; Qingfei Liu; Zhao Wang
Journal:  Acta Pharm Sin B       Date:  2021-08-06       Impact factor: 11.413

3.  Variation in Tap Water Mineral Content in the United Kingdom: Is It Relevant for Kidney Stone Disease?

Authors:  Kirolos G F T Michael; Bhaskar K Somani
Journal:  J Clin Med       Date:  2022-08-30       Impact factor: 4.964

Review 4.  Molecular mechanisms altering tubular calcium reabsorption.

Authors:  Mallory L Downie; R Todd Alexander
Journal:  Pediatr Nephrol       Date:  2021-04-01       Impact factor: 3.714

Review 5.  Nutrition and Kidney Stone Disease.

Authors:  Roswitha Siener
Journal:  Nutrients       Date:  2021-06-03       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.